Rudek MA - Search Results

1

Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors.

Jimeno A, Rudek MA, Purcell T, Laheru DA, Messersmith WA, Dancey J, Carducci MA, Baker SD, Hidalgo M, Donehower RC. Jimeno A, et al. Among authors: rudek ma. Cancer Chemother Pharmacol. 2008 Mar;61(3):423-33. doi: 10.1007/s00280-007-0485-9. Epub 2007 Apr 12. Cancer Chemother Pharmacol. 2008. PMID: 17429623 Free PMC article. Clinical Trial.

2

Development of matrix metalloproteinase inhibitors in cancer therapy.

Purcell WT, Rudek MA, Hidalgo M. Purcell WT, et al. Among authors: rudek ma. Hematol Oncol Clin North Am. 2002 Oct;16(5):1189-227. doi: 10.1016/s0889-8588(02)00044-8. Hematol Oncol Clin North Am. 2002. PMID: 12512389 Review.

3

Specific method for determination of OSI-774 and its metabolite OSI-420 in human plasma by using liquid chromatography-tandem mass spectrometry.

Zhao M, He P, Rudek MA, Hidalgo M, Baker SD. Zhao M, et al. Among authors: rudek ma. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Aug 15;793(2):413-20. doi: 10.1016/s1570-0232(03)00356-8. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12906916

4

A rapid and sensitive method for determination of dimethyl benzoylphenyl urea in human plasma by using LC/MS/MS.

Zhao M, Zabelina Y, Rudek MA, Wolff AC, Baker SD. Zhao M, et al. Among authors: rudek ma. J Pharm Biomed Anal. 2003 Nov 24;33(4):725-33. doi: 10.1016/s0731-7085(03)00424-2. J Pharm Biomed Anal. 2003. PMID: 14623599

5

Temozolomide in patients with advanced cancer: phase I and pharmacokinetic study.

Rudek MA, Donehower RC, Statkevich P, Batra VK, Cutler DL, Baker SD. Rudek MA, et al. Pharmacotherapy. 2004 Jan;24(1):16-25. doi: 10.1592/phco.24.1.16.34800. Pharmacotherapy. 2004. PMID: 14740784 Clinical Trial.

6

Synthesis and antitumor evaluation of benzoylphenylurea analogs.

Gurulingappa H, Amador ML, Zhao M, Rudek MA, Hidalgo M, Khan SR. Gurulingappa H, et al. Among authors: rudek ma. Bioorg Med Chem Lett. 2004 May 3;14(9):2213-6. doi: 10.1016/j.bmcl.2004.02.019. Bioorg Med Chem Lett. 2004. PMID: 15081011

7

Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy.

Rudek MA, Sparreboom A, Garrett-Mayer ES, Armstrong DK, Wolff AC, Verweij J, Baker SD. Rudek MA, et al. Eur J Cancer. 2004 May;40(8):1170-8. doi: 10.1016/j.ejca.2003.12.026. Eur J Cancer. 2004. PMID: 15110880

8

A method for determination of dimethyl benzoylphenyl urea (BPU) in human plasma by using LC/UV.

Rudek MA, Zabelina Y, Zhao M, Wolff AC, Baker SD. Rudek MA, et al. Biomed Chromatogr. 2004 Jun;18(5):282-7. doi: 10.1002/bmc.314. Biomed Chromatogr. 2004. PMID: 15236435

9

Quantification of 5-azacytidine in plasma by electrospray tandem mass spectrometry coupled with high-performance liquid chromatography.

Zhao M, Rudek MA, He P, Hartke C, Gore S, Carducci MA, Baker SD. Zhao M, et al. Among authors: rudek ma. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):81-8. doi: 10.1016/j.jchromb.2004.09.012. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 15556519

10

Validation and implementation of a method for determination of bryostatin 1 in human plasma by using liquid chromatography/tandem mass spectrometry.

Zhao M, Rudek MA, He P, Smith BD, Baker SD. Zhao M, et al. Among authors: rudek ma. Anal Biochem. 2005 Feb 1;337(1):143-8. doi: 10.1016/j.ab.2004.10.030. Anal Biochem. 2005. PMID: 15649387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters